Adco Allopurinol 300 mg Tablets

    Adco Allopurinol 300 mg Tablets

    S3
    PDF Leaflet Revision Date: 26 November 2024

    API: Allopurinol | Company: Adcock Ingram

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of gout and hyperuricaemia.

    Dosage (summary)

    Up to 300 mg once daily; may increase to 600 mg in severe cases.

    Special Populations

    • Renal impairment
    • Hepatic impairment

    Pregnancy & Breastfeeding

    Contraindicated in pregnancy and lactation.

    Key Drug Interactions

    • Mercaptopurine
    • Azathioprine
    • Chlorpropamide
    • Warfarin
    • Theophylline

    Contraindications

    • Hypersensitivity
    • Pregnancy
    • Lactation
    • Children (except malignancy)
    • Acute gout

    Common side effects

    • Skin rash
    • Nausea
    • Vomiting
    • Headache
    • Drowsiness

    Counselling Points

    • Take after meals for better tolerance
    • Maintain high fluid intake
    • Monitor for skin reactions

    Serious warnings

    • Hypersensitivity reactions
    • Risk of acute gout attack
    • Monitor for skin reactions
    Important Disclaimer

    The Adco Allopurinol 300 mg Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn